News
Stories about the companies we track, gathered daily from UK and European tech press and Google News. Headlines link to the original publisher.
- ProductDrug Target Review, 20 days agobit.bio launches refined human astrocyte model for neurotoxicity assessment
- ExpansionPharmafile, 30 Sept 2026bit.bio expands human heart cell portfolio through myriamed partnership
- OtheropenPR.com, 23 Sept 2026myriamed Brings Human Cardiomyocytes to the Global Drug Discovery Market via bit.bio
- LeadershipScientific Computing World, 13 Aug 2026bit.bio announces CRISPR screening service and appoints Chief Technology Officer
- OtherBusiness Weekly, 12 Jul 2026Business for bit.bio CEO Dr Emma Pepperell can appear to an external observer to be as straightforward as ABC
- Otherthepharmaletter.com, 6 Jul 2026bit.bio cuts cost of human cell culture by 18x with new media kits
- Productdrugtargetreview.com, 6 Jul 2026bit.bio launches iPSC-derived cell culture media kits to democratise human cell research
- LeadershipBusiness Weekly, 14 Jun 2026New CEO unveiled at Cambridge-based bit.bio
- OtherBusiness Weekly, 9 Jun 2026bit.bio sets out vision to power 'radical change in drug discovery' at Human Cell Forum
- Otherdrugtargetreview.com, 1 Jun 2026Parse Biosciences and bit.bio map transcription factor-driven cell identity
- ProductDrug Discovery News, 28 May 2026Parse and bit.bio launch effort to build blueprint for predictive human cell models
- OtherBusiness Weekly, 27 May 2026bit.bio and Parse Biosciences in drug discovery alliance
- Partnerships & dealscambridgeindependent.co.uk, 25 Feb 2026bit.bio drops prices and partners SciSafe for US/European distribution hubs
- ExpansionBusiness Weekly, 22 Feb 2026bit.bio expands on back of lower prices and broader distribution model
- OtherBusiness Wire, 19 Feb 2026bit.bio Accelerates Global Access to Human Cells with New Pricing Model and Distribution Hub
- FundingHealthcare Today, 23 Jan 2026bit.bio raises $50 million Series C funding
- FundingCambridge Independent, 16 Jan 2026Series C $50m boosts bit.bio in new era of cell test opportunities
- Fundingpulse2.com, 10 Jan 2026bit.bio Raises $50 Million Series C Led by M&G To Scale Human Cell Programming Platform
- OtherBioSpace, 2 Dec 2025bit.bio Publishes 2025 Sustainability Report
- ProductEndpoints News, 2 Jun 2025Exclusive: Stem cell scientist and bit.bio founder launches new startup with goal of extending healthspan by 20 years
